从昼夜节律中学习,改变癌症预防,预后和幸存者护理
Xiaoyan Zhu1, Geraldine Maier1, Satchidananda Panda1
1The Salk Institute for Biological Studies, La Jolla, CA, USA.
Trends in cancer
|November 24, 2023
概括
该研究强调了昼夜节律和细胞周期调节之间的联系,这对于癌症预防和治疗至关重要. 了解这些生物节奏可以优化癌症治疗,减少副作用.
科学领域:
- 时间生物学 时间生物学
- 癌症生物学 癌症生物学
- 代谢调节 代谢调节 代谢调节 代谢调节
背景情况:
- 循环节律和细胞循环控制共享基本的生物过程.
- 人们越来越多地认识到昼夜时钟组件和细胞周期调节器之间的相互作用.
- 睡眠,饮食和活动等生活方式因素影响昼夜适应能力和癌症风险.
研究的目的:
- 在癌症的背景下,探索昼夜计时和细胞周期调节之间的相互作用.
- 研究如何循环节控制新陈代谢可以告知癌症治疗时间.
- 检查生活方式驱动的昼夜适应能力在癌症预防和管理中的作用.
主要方法:
- 关于昼夜生物学和细胞周期调节的最新科学文献的综述.
- 对调查时钟基因和细胞循环蛋白之间的分子相互作用的研究进行分析.
- 探索连接生活方式因素,昼夜干扰和癌症发病率的流行病学数据.
主要成果:
- 共同的生物原理控制着昼夜节律和细胞周期控制,包括信号响应,DNA修复和资源分配.
- 循环时钟组件和细胞循环调节器表现出显著的相互作用,呈现出新的治疗点.
- 循环代谢调节为时间疗法提供了机会,以提高癌症治疗效率并减少毒性.
- 影响昼夜节律的生活方式修改对于癌症预防和生存至关重要.
结论:
- 将昼夜原则纳入癌症护理,从预防到治疗和生存,是必不可少的.
- 利用昼夜适应能力和准昼夜通路对个性化癌症干预有重大前景.
- 监测昼夜健康可以提高风险评估和指导整个癌症连续性的干预措施.
相关概念视频
02:19Circadian Rhythms and Gene Regulation
4.1K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.1K
01:21Cancer Survival Analysis
356
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
356
02:39Positive Regulator Molecules
5.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.5K
02:59Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K